Holen Sie sich die Stockscreener-App
63.36
0.49%
-0.31
Schlusskurs vom Vortag:
$63.67
Offen:
$64.23
24-Stunden-Volumen:
467.19K
Relative Volume:
0.84
Marktkapitalisierung:
$3.46B
Einnahmen:
$1.28B
Nettoeinkommen (Verlust:
$-222.15M
KGV:
-15.49
EPS:
-4.09
Netto-Cashflow:
$145.52M
1W Leistung:
-0.71%
1M Leistung:
+24.70%
6M Leistung:
+41.27%
1J Leistung:
+25.47%
1-Tages-Spanne:
$62.85
$64.45
1-Wochen-Bereich:
$62.32
$64.45
52-Wochen-Spanne:
$32.48
$64.45
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Vergleichen Sie LIVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
63.36 | 3.49B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
125.08 | 218.05B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.52 | 144.86B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.02 | 139.34B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.36 | 130.75B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.19 | 49.78B | 5.88B | 1.34B | 799.60M | 2.3489 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
Improved Revenues Required Before LivaNova PLC (NASDAQ:LIVN) Stock's 26% Jump Looks Justified - simplywall.st
LivaNova PLC $LIVN Shares Sold by Kennedy Capital Management LLC - MarketBeat
Legal & General Group Plc Has $4.09 Million Stake in LivaNova PLC $LIVN - MarketBeat
LivaNova (NASDAQ:LIVN) Downgraded by Wall Street Zen to Buy - MarketBeat
Why institutional investors increase stakes in LivaNova PLC (LIA) stockQuarterly Market Summary & Daily Stock Trend Watchlist - Newser
Prudential Financial Inc. Sells 71,065 Shares of LivaNova PLC $LIVN - MarketBeat
Will LivaNova PLC stock gain from strong economyWeekly Trade Recap & Verified Momentum Watchlists - Newser
How LivaNova PLC (LIA) stock reacts to fiscal policiesDividend Hike & Stepwise Trade Execution Plans - Newser
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting - facilitiesmanagement-now.com
LivaNova (NASDAQ:LIVN) Hits New 52-Week HighHere's What Happened - MarketBeat
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea - MSN
LivaNova (Nasdaq: LIVN) to present CORE-VNS seizure and cost data at AES 2025 - Stock Titan
LivaNova appoints Lucile Blaise to lead sleep apnea commercialization By Investing.com - Investing.com Australia
LivaNova stock hits 52-week high at 64.1 USD By Investing.com - Investing.com India
LivaNova stock hits 52-week high at 64.1 USD - Investing.com
LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025 - marketscreener.com
LivaNova appoints Lucile Blaise to lead sleep apnea commercialization - Investing.com
Livanova appoints Lucile Blaise as global head of commercialization, obstructive sleep apnea - marketscreener.com
LivaNova names Lucile Blaise global head of sleep apnea unit - StreetInsider
LivaNova PLC $LIVN Shares Acquired by Capital Fund Management S.A. - MarketBeat
Why LivaNova PLC (LIA) stock remains top ratedJuly 2025 Short Interest & Weekly Stock Performance Updates - Newser
Is LivaNova PLC (LIA) stock a buy before new product rolloutJuly 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
Creative Planning Buys New Shares in LivaNova PLC $LIVN - MarketBeat
LivaNova (LIVN) Is Up 5.5% After Medicare Boosts VNS Therapy Reimbursement—Has the Bull Case Changed? - simplywall.st
F m Investments LLC Raises Stake in LivaNova PLC $LIVN - MarketBeat
Is LivaNova PLC stock attractive for income investorsPortfolio Gains Report & Weekly Hot Stock Watchlists - BỘ NỘI VỤ
Behavioral Patterns of LIVN and Institutional Flows - news.stocktradersdaily.com
Paradice Investment Management LLC Raises Stake in LivaNova PLC $LIVN - MarketBeat
A Look at LivaNova's (LIVN) Valuation Following Its Recent 20% Share Price Surge - Yahoo Finance UK
North America Heart Pump Device Market Forecast and Company Analysis Report 2025-2033 Featuring Abbott, Getinge, Teleflex, Fresenius, LivaNova, CorWave, JARVIK HEART, ABIOMED - Yahoo Finance
FOMO Trade: How buybacks impact LivaNova PLC stock value2025 Performance Recap & Long-Term Investment Growth Plans - moha.gov.vn
Rhenman & Partners Asset Management AB Acquires New Stake in LivaNova PLC $LIVN - MarketBeat
Is LivaNova PLC (LIA) stock prepared for digital transitionJuly 2025 Final Week & Daily Stock Trend Watchlist - BỘ NỘI VỤ
LivaNova to Present at Piper Sandler Healthcare Conference in December - Enidnews.com
Perfusion Systems Market Set to Witness Significant Growth - openPR.com
LivaNova PLC (LIVN) Stock Forecasts - Yahoo Finance
Heater-Cooler Devices: Side Effects, Recalls & Lawsuit Information - Drugwatch.com
A Look at LivaNova's Valuation After CMS Lifts Medicare Payments for VNS Therapy - Sahm
LivaNova stock hits 52-week high at 59.69 USD By Investing.com - Investing.com Nigeria
LivaNova PLC's VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services - MarketScreener
LivaNova stock hits 52-week high at 59.69 USD - Investing.com
LivaNova (LIVN) Gains CMS Approval for Higher Medicare Reimbursement - GuruFocus
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services - Yahoo Finance
Cardiac Prosthetic Devices Market revenue to cross USD 17.4 - openPR.com
The Bull Case For LivaNova (LIVN) Could Change Following Q3 Beat and Ambitious 2030 Growth Targets - simplywall.st
Will LivaNova PLC (LIA) stock test record highs in 2025Trade Risk Summary & Fast Moving Stock Watchlists - newser.com
Story Brooke sells $13k in LivaNova PLC (LIVN) shares By Investing.com - Investing.com India
How LivaNova PLC stock reacts to job market data2025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
Can LivaNova PLC stock hit record highs againJuly 2025 Sentiment & Weekly Market Pulse Alerts - newser.com
Using data models to predict LivaNova PLC stock movementQuarterly Market Summary & Verified Chart Pattern Signals - newser.com
Can LivaNova PLC (LIA) stock surprise with quarterly resultsWall Street Watch & Low Risk High Reward Ideas - newser.com
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.78%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):